| Popis: |
Abstract Background Esophageal squamous cell carcinoma (ESCC), an aggressive gastrointestinal tumor, often has high early lymphatic metastatic potential. Cancer‐associated fibroblasts (CAFs) are primary components in tumor microenvironment (TME), and the impact of CAFs and its derived exosomes on lymphangiogenesis remains elusive. Materials and Methods CAFs and the microlymphatic vessel density (MLVD) in ESCC was examined. Exosomes were extracted from primary normal fibroblast (NFs) and CAFs. Subsequently, tumor‐associated lymphatic endothelial cells (TLECs) were treated with these exosomes, and the effect on their biological behavior was examined. miR‐100‐5p was selected as the target miRNA, and its effect on TLECs was examined. The target of miR‐100‐5p was predicted and confirmed. Subsequently, IGF1R, PI3K, AKT, and p‐AKT expression in TLECs and tumors treated with exosomes and miR‐100‐5p were examined. Results A large number of CAFs and microlymphatic vessels were present in ESCC, leading to a poor prognosis. CAF‐derived exosomes promoted proliferation, migration, invasion, and tube formation in TLECs. Further, they also enhanced lymphangiogenesis in ESCC xenografts. miR‐100‐5p levels were significantly lower in CAF‐derived exosomes than in NF‐derived exosomes. miR‐100‐5p inhibited proliferation, migration, invasion, and tube formation in TLECs. Further, miR‐100‐5p inhibited lymphangiogenesis in ESCC xenografts. Mechanistic studies revealed that this inhibition was mediated by the miR‐100‐5p‐induced inhibition of IGF1R/PI3K/AKT axis. Conclusion Taken together, our study demonstrates that CAF‐derived exosomes with decreased miR‐100‐5p levels exhibit pro‐lymphangiogenesis capacity, suggesting a possibility of targeting IGF1R/PI3K/AKT axis as a strategy to inhibit lymphatic metastasis in ESCC. |
